Home » Stocks » Steris

Steris PLC (STE)

Stock Price: $185.95 USD -0.39 (-0.21%)
Updated Oct 21, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 15.82B
Revenue (ttm) 3.00B
Net Income (ttm) 411.21M
Shares Out 85.05M
EPS (ttm) 4.80
PE Ratio 38.74
Forward PE 29.59
Dividend $1.60
Dividend Yield 0.86%

Stock Quote

Trading Day Oct 21, 2020
Last Price $185.95
Previous Close $186.34
Change ($) -0.39
Change (%) -0.21%
Day's Open 186.23
Day's Range 185.66 - 187.56
Day's Volume 181,168
52-Week Range 105.69 - 192.97

More Stats

Market Cap 15.82B
Enterprise Value 16.76B
Earnings Date (est) Nov 2, 2020
Ex-Dividend Date Aug 26, 2020
Shares Outstanding 85.05M
Float 84.59M
EPS (basic) 4.86
EPS (diluted) 4.80
FCF / Share 4.57
Dividend $1.60
Dividend Yield 0.86%
Earnings Yield 2.58%
FCF Yield 2.45%
Payout Ratio 30.50%
Shares Short 1.28M
Short Ratio 2.47
Short % of Float 1.51%
Beta 0.66
PE Ratio 38.74
Forward PE 29.59
P/FCF Ratio 40.76
PS Ratio 5.27
PB Ratio 4.56
Revenue 3.00B
Operating Income 540.89M
Net Income 411.21M
Free Cash Flow 388.04M
Net Cash -947.26M
Net Cash / Share -11.14
Gross Margin 44.04%
Operating Margin 18.01%
Profit Margin 13.70%
FCF Margin 12.92%
ROA 6.50%
ROE 12.21%
ROIC 18.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (7)

Buy 2
Overweight 1
Hold 4
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

(7.56% upside)
Current: $185.95
Target: 200.00
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth8.94%6.19%0.28%16.71%21%14.06%-
Gross Profit1,3201,1751,0931,026895774650
Operating Income537411400226213227207
Net Income408304291110111135129
Shares Outstanding84.8184.5984.8584.9385.90--
Earnings Per Share4.763.563.391.281.562.252.17
EPS Growth33.71%5.01%164.84%-17.95%-30.67%3.69%-
Dividend Per Share1.451.331.211.090.25--
Dividend Growth9.02%9.92%11.01%336%---
Operating Cash Flow591540458424255246210
Capital Expenditures-210-184-163-168-126-84.43-81.59
Free Cash Flow380355294256129162128
Cash & Equivalents320221202283249168-
Total Debt1,2841,1831,3161,4781,568621-
Net Cash / Debt-965-963-1,114-1,195-1,319-453-
Book Value3,3943,1783,2062,7993,0231,072-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Steris PLC
Country Ireland
Employees 13,000
CEO Walter M. Rosebrough

Stock Information

Ticker Symbol STE
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NYSE: STE
IPO Date June 1, 1992


STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services. This segment offers its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, such as instrument and endoscope repair and maintenance solutions; custom process improvement consulting services; and outsourced instrument sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The company was founded in 1985 and is based in Dublin, Ireland.